Rose Mueller, PA
Medical · Lawrence, KSNPI 1336697408
Payments from drug & device makers
Across 65 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$217
- Novo Nordisk$153
- Teva Pharmaceuticals USA, Inc.$135
- Lilly USA, LLC$115
- Gilead$90
- Otsuka America Pharmaceutical, Inc.$76
- plus $306 from 14 others
What the payments were for
- Food & beverage$1,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $217 |
| Novo Nordisk | 10 | $153 |
| Teva Pharmaceuticals USA, Inc. | 8 | $135 |
| Lilly USA, LLC | 8 | $115 |
| Gilead | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 5 | $76 |
| Alkermes, Inc. | 2 | $49 |
| Viiv Healthcare Company | 2 | $37 |
| Braeburn Inc. | 1 | $30 |
| Merck | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Organon | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,093 in reported general payments places this provider in the 55th percentile of 205 medical providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 74 | $77,319 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $44,061 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $33,321 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 42 | $28,365 |
| RexultiBrexpiprazole | 13 | $19,120 |
| LinzessLinaclotide | 24 | $16,461 |
| MounjaroTirzepatide | 12 | $13,436 |
| EliquisApixaban | 11 | $13,400 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,825 |
| JardianceEmpagliflozin | 13 | $9,980 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,316 |
| Praluent PenAlirocumab | 13 | $6,435 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 29 | $5,479 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 69 | $5,284 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $2,226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $153 | $77,31974 claims |
| MerckJanumet Xr | $24 | $28,36542 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $76 | $19,12013 claims |
| AbbVieLinzess, Synthroid | $217 | $17,84739 claims |
| Lilly USA, LLCMounjaro | $115 | $13,43612 claims |
| Boehringer IngelheimJardiance | $17 | $9,98013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 205 medical providers in Kansas.
Other medical in Lawrence
- Britani CongletonLawrence$6K
- Misty ChambersLawrence$6K
- Brooke BennettLawrence$4K
- Abigail StoneLawrence$3K
- Linly StevensOverland Park$111K
- Shana ArnholdShawnee$82K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.